文献速递免疫规划

单剂聚酐基疫苗平台促进并维持抗GnRH抗体滴度

A single dose polyanhydride-based vaccine platform promotes and maintains anti-GnRH antibody titers.
PubMed 文献 · Vaccine · 2018-01-01

研究在小鼠中测试一种三阶段疫苗平台:可溶性GnRH多抗原肽(GnRH-MAP)注射,联合皮下给予聚酐固定化GnRH-MAP及含GnRH-MAP树状大分子聚酐植入物,单次接种后细胞免疫与体液免疫维持至41周,抗体亲和力随时间增强,但未实现不育。

要点

  • 单次接种后细胞免疫与体液免疫维持至41周。
  • 抗体亲和力随时间增强。
  • 所有完整植入物可见组织界面伴新生血管与淋巴细胞聚集。

核心结论

  • 单剂三阶段聚酐基疫苗平台可在小鼠中生成并维持抗GnRH免疫达41周,但未实现不育,也未导致雄性无精或阻止雌性发情与排卵。
  • 该疫苗递送装置可调,免疫原、佐剂与释放速率均可修改以增强免疫。
  • 该技术对长期疫苗接种方案开发具有广泛意义。

研究设计与样本

  • 研究为小鼠实验,采用三阶段疫苗平台:可溶性GnRH多抗原肽(GnRH-MAP)注射,联合皮下给予聚酐固定化GnRH-MAP及含GnRH-MAP树状大分子聚酐植入物。
  • 单次接种后观察免疫应答至41周。

主要发现

  • 单次接种后细胞免疫与体液免疫维持至41周。
  • 抗体亲和力随时间增强。
  • 所有完整植入物可见肉眼可见的组织界面,伴新生血管与淋巴细胞聚集。
  • 尽管可检测到免疫,但未实现不育,免疫应答未导致雄性小鼠无精,也未阻止雌性小鼠发情与排卵。

临床怎么用

  • 作者认为该疫苗递送装置可调,免疫原、佐剂与释放速率均可修改以增强免疫。
  • 作者认为该技术对长期疫苗接种方案开发具有广泛意义。

局限性

  • 尽管可检测到免疫,但未实现不育,免疫应答未导致雄性小鼠无精,也未阻止雌性小鼠发情与排卵。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Traditionally, vaccination strategies require an initial priming vaccination followed by an antigen boost to generate adequate immunity. Here we describe vaccination against a self-peptide for reproductive sterilization utilizing a three-stage vaccine platform consisting of gonadotropin releasing hormone multiple antigenic peptide (GnRH-MAP) as a soluble injection coupled with subcutaneous administration of polyanhydride-immobilized GnRH-MAP and a cyto-exclusive implant containing GnRH-MAP dendrimer-loaded polyanhydride. This strategy generated and maintained cell-mediated and humoral immunity for up to 41 weeks after a single vaccination in mice with enhanced antibody avidity over time. All intact implants had a grossly visible tissue interface with neovascularization and lymphocytic aggregates. Despite detectable immunity, sterility was not achieved and the immune response did not lead to azoospermia in male mice nor prevent estrus and ovulation in female mice. However, the vaccine delivery device is tunable and the immunogen, adjuvants and release rates can all be modified to enhance immunity. This technology has broad implications for the development of long-term vaccination schemes.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Schaut RG, Brewer MT, Hostetter JM, et al. A single dose polyanhydride-based vaccine platform promotes and maintains anti-GnRH antibody titers. Vaccine. 2018. PMID: 29413092. doi:10.1016/j.vaccine.2017.12.050

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。